Fox Chase Cancer Center Radiation Oncologist Joins State Task Force on Prostate Cancer

Eric M. Horwitz, MD
Eric M. Horwitz, MD

PHILADELPHIA (February 22, 2016) — Eric M. Horwitz, MD, chair of radiation oncology at Fox Chase Cancer Center, has been appointed to the Pennsylvania Task Force on Prostate Cancer and Related Chronic Prostate Conditions (PCTF) by Pennsylvania Secretary of Health Dr. Karen Murphy.

Horwitz joins other radiation oncologists, registered nurses, urologists, state health officials, and prostate cancer patients tasked with investigating, raising awareness and making recommendations concerning prostate cancer and related conditions. The task force will issue a report with recommendations to the Secretary of Health within one year of its first meeting, which took place on Thursday, Feb. 18.

“I’m honored and excited to be working with talented health professionals and patients to advance prostate cancer treatment and comprehensive prostate cancer control in Pennsylvania,” Horwitz said. “These guidelines will bring much needed attention to this devastating disease, and will help inform Pennsylvania residents about how they can decrease their prostate cancer risk.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text